Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel–Lindau-dependent pathway

Author： Li Ching-Hao   Liao Po-Lin   Yang Ya-Ting   Huang Shih-Hsuan   Lin Cheng-Hui   Cheng Yu-Wen   Kang Jaw-Jou  

Publisher： Springer Publishing Company

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.88, Iss.3, 2014-03, pp. : 659-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia

By Yan Lin   Colandrea Vincent J   Hale Jeffrey J  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1219-1245

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-07 ,pp. : 1295-1304

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-01 ,pp. : 1305-1310

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting hypoxia-inducible factor-1 for therapy and prevention

By Zhong Hua  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 951-966

Informa Healthcare

Access to resources Recommend Favorite

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 782-796

Bentham Science Publishers

Access to resources Recommend Favorite